Applications for the projects below will open on Monday 16 October 2023 and close on Monday 8 January 2024 at 17.00 (GMT)
Impact of novel activating antibodies targeting microglial TREM2 in a human triculture AD model
Impact of novel activating antibodies targeting microglial TREM2 in a human triculture AD model
Professor Jennifer Pocock (UCL Queen Square Institute of Neurology) and Dr Michael Perkinton (AstraZeneca, Cambridge, UK)
Professor Jennifer Pocock (UCL Queen Square Institute of Neurology) and Dr Michael Perkinton (AstraZeneca, Cambridge, UK)
Optimising deep brain stimulation for treatment of epilepsy: a networks based approach
Optimising deep brain stimulation for treatment of epilepsy: a networks based approach
Mr Martin Tisdall (UCL), Professor Torsten Baldeweg (UCL) and Dr Tim Denison (Amber Therapeutics Ltd.)
Mr Martin Tisdall (UCL), Professor Torsten Baldeweg (UCL) and Dr Tim Denison (Amber Therapeutics Ltd.)
Understanding the contribution of the glycome and specific plasma glycoproteins to the onset of non-communicable diseases in people with HIV
Understanding the contribution of the glycome and specific plasma glycoproteins to the onset of non-communicable diseases in people with HIV
Professor Caroline Sabin (UCL), Professor Alan Winston (Imperial College London), Professor Paddy Mallon (University College Dublin) and Dr Daniel Spencer (Ludger Ltd)
Professor Caroline Sabin (UCL), Professor Alan Winston (Imperial College London), Professor Paddy Mallon (University College Dublin) and Dr Daniel Spencer (Ludger Ltd)
Defining B cell gene signatures associated with higher affinity antibodies
Defining B cell gene signatures associated with higher affinity antibodies
Professor Laura McCoy (UCL) and Mr Trevor Wattam (GlaxoSmithKline)
Professor Laura McCoy (UCL) and Mr Trevor Wattam (GlaxoSmithKline)